Sage Mountain Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-150
Closed -$9K – 622
2021
Q4
$9K Buy
+150
New +$10.4K ﹤0.01% 670

Other funds holding ARKG

Sage Mountain Advisors's ARKG Position: Q1 2022 in Review

Sage Mountain Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 150 shares — an estimated $9K sold.

Sage Mountain Advisors first reported a position in ARKG in Q4 2021 and held it in 1 quarter. The position peaked at $9K in Q4 2021. 388 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

  • Sage Mountain Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
  • Sage Mountain Advisors sold 150 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $9K.
  • Sage Mountain Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 1 quarter.
  • Sage Mountain Advisors's ARK Genomic Revolution ETF position peaked at $9K in Q4 2021.
  • 388 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Sage Mountain Advisors's 13F filing for Q1 2022, filed 10 May 2022.